Sign In
Buy ELVN
Enliven Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -92.25. In total, the insiders bought 1.38M and sold 1.71M ELVN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-92.25 |
| ● Buy | 1.38M shares |
| ● Sell | 1.71M shares |
|
46% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Aug 04, 2026 Sell |
Derynck Mika K Director |
158 795 Value: $9.56M |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
23 364 Value: $347.0K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
87 373 Value: $216.7K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
23 364 Value: $347.0K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
27 567 Value: $696.9K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
20 491 Value: $460.4K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
87 373 Value: $216.7K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
20 491 Value: $460.4K |
||
|
Aug 04, 2026 Buy |
Derynck Mika K Director |
27 567 Value: $696.9K |
||
|
Jul 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
369 Value: $19.0K |
||
|
Jul 17, 2026 Buy |
Hohl Benjamin Chief Financial Officer |
1 072 Value: $3K |
||
|
Jul 17, 2026 Buy |
Hohl Benjamin Chief Financial Officer |
1 072 Value: $3K |
||
|
Jul 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
231 Value: $11.6K |
||
|
Jul 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
459 Value: $23.7K |
||
|
Jul 17, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
||
|
Jul 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
2 638 Value: $140.8K |
||
|
Jul 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
2 564 Value: $134.1K |
||
|
Jul 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
123 Value: $7K |
||
|
Jul 17, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
||
|
Jul 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
2 184 Value: $116.7K |
||
|
Jul 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
2 063 Value: $108.1K |
||
|
Jul 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
63 Value: $3K |
||
|
Jul 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
324 Value: $16.2K |
||
|
Jul 06, 2026 Sell |
Kunkel Lori Anne Director |
5 889 Value: $299.4K |
||
|
Jul 06, 2026 Sell |
Kunkel Lori Anne Director |
4 111 Value: $205.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
